Genetic Basis for Congenital Heart Disease: Revisited: A Scientific Statement From the American Heart Association

Генетическая основа врождённых пороков сердца: пересмотр: научное заявление Американской кардиологической ассоциации
William T. Pu, Seema Mital, Amy E. Roberts, Amy L. McGuire, Wendy K. Chung, Martina Brueckner, Bruce D. Gelb, Vidu Garg, Mary Ella Pierpont, Ronald V. Lacro, James R. Priest, Stephanie M. Ware, Mark W. W. Russell
2018-10-16

RASopathiescongenital heart diseasecopy number variantsgenetic contributionsmolecular testing techniques
This review provides an updated summary of the state of our knowledge of the genetic contributions to the pathogenesis of congenital heart disease. Since 2007, when the initial American Heart Association scientific statement on the genetic basis of congenital heart disease was published, new genomic techniques have become widely available that have dramatically changed our understanding of the causes of congenital heart disease and, clinically, have allowed more accurate definition of the pathogeneses of congenital heart disease in patients of all ages and even prenatally. Information is presented on new molecular testing techniques and their application to congenital heart disease, both isolated and associated with other congenital anomalies or syndromes. Recent advances in the understanding of copy number variants, syndromes, RASopathies, and heterotaxy/ciliopathies are provided. Insights into new research with congenital heart disease models, including genetically manipulated animals such as mice, chicks, and zebrafish, as well as human induced pluripotent stem cell-based approaches are provided to allow an understanding of how future research breakthroughs for congenital heart disease are likely to happen. It is anticipated that this review will provide a large range of health care-related personnel, including pediatric cardiologists, pediatricians, adult cardiologists, thoracic surgeons, obstetricians, geneticists, genetic counselors, and other related clinicians, timely information on the genetic aspects of congenital heart disease. The objective is to provide a comprehensive basis for interdisciplinary care for those with congenital heart disease.
1
Genetically manipulated animal models and human induced pluripotent stem-cell approaches provide important platforms for discovering future congenital heart disease mechanisms and therapies.
2
Genomic technologies introduced since 2007 have substantially advanced understanding of the genetic causes and pathogenesis of congenital heart disease.
3
New molecular testing methods enable more accurate etiologic diagnosis of congenital heart disease across ages, including prenatal evaluation.
4
The review synthesizes genetic mechanisms underlying isolated congenital heart disease and cases associated with anomalies, syndromes, copy-number variants, RASopathies, and heterotaxy/ciliopathies.
5
The statement establishes a comprehensive genetic framework intended to support interdisciplinary clinical care for patients with congenital heart disease.

Congenital heart disease (patients and experimental models including genetically manipulated animals and human iPSC-based models)

the genetic contributions and molecular mechanisms underlying the pathogenesis of congenital heart disease, including copy number variants, syndromes, RASopathies, and heterotaxy/ciliopathies

Publication Details
Publication Date
2018-10-16
Journal
Publisher
ISSN
Access Type
Author Information
Authors
William T. Pu
Seema Mital
Amy E. Roberts
Amy L. McGuire
Wendy K. Chung
Martina Brueckner
Bruce D. Gelb
Vidu Garg
Mary Ella Pierpont
Ronald V. Lacro
James R. Priest
Stephanie M. Ware
Mark W. W. Russell
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%